Healthcare trust provider, Healix Health, has updated its cancer care offering with the launch of a precision cancer service.
The service has been developed in partnership with global healthcare solutions provider, Further, as an extension of its existing cancer care pathway. As part of the offering, Healix said there will be advanced genomic testing with clinical support, embedding precision medicine into the cancer pathway. The precision cancer service is available for a fixed annual fee per principal member, including spouse and dependents. It is available to employees diagnosed with stage three or four cancer, rare cancers, cancers of unknown primary and cancers that have not responded to first line trea...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.